Amylyx Pharmaceuticals (AMLX) Stock Chart & Stock Price History $3.43 -0.08 (-2.28%) Closing price 04/4/2025 04:00 PM EasternExtended Trading$3.42 -0.01 (-0.15%) As of 04/4/2025 04:54 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Amylyx Pharmaceuticals Stock Price Performance 5 Day Performance-3.11%1 Month Performance+2.08%3 Month Performance-17.35%6 Month Performance+9.94%Year-To-Date Performance-9.26%1 Year Performance+30.92% Receive AMLX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Amylyx Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address AMLX Stock Chart for Sunday, April, 6, 2025 AMLX Chart by TradingViewRemove Ads Amylyx Pharmaceuticals Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization04/04/2025$3.51$3.43-2.28%$3.56$3.26914,194 shs$303.91 million04/03/2025$3.78$3.51-7.14%$3.73$3.42721,334 shs$310.99 million04/02/2025$3.34$3.78+13.17%$3.83$3.23771,115 shs$334.92 million04/01/2025$3.54$3.34-5.65%$3.54$3.301.53 million shs$295.93 million03/31/2025$3.66$3.54-3.28%$3.63$3.441.06 million shs$313.65 million03/28/2025$3.87$3.66-5.43%$3.85$3.55515,392 shs$324.28 million03/27/2025$3.81$3.87+1.57%$3.93$3.65711,856 shs$342.89 million03/26/2025$3.78$3.81+0.79%$3.87$3.59432,087 shs$337.57 million03/25/2025$3.78$3.78$4.00$3.64701,137 shs$334.92 million03/24/2025$3.65$3.78+3.56%$3.79$3.61402,438 shs$334.92 million Get the Latest News and Ratings for AMLX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Amylyx Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 03/21/2025$3.73$3.65-2.14%$3.81$3.631.51 million shs$323.40 million03/20/2025$3.65$3.73+2.19%$3.84$3.64366,534 shs$330.49 million03/19/2025$3.64$3.65+0.27%$3.71$3.55359,790 shs$323.40 million03/18/2025$3.75$3.64-2.93%$3.77$3.60560,210 shs$322.51 million03/17/2025$3.63$3.75+3.31%$3.82$3.57421,607 shs$332.26 million03/14/2025$3.67$3.63-1.09%$3.83$3.54517,052 shs$248.83 million03/13/2025$3.91$3.67-6.14%$3.99$3.60633,131 shs$251.57 million03/12/2025$3.73$3.91+4.83%$4.10$3.731.34 million shs$268.02 million03/11/2025$3.49$3.73+6.88%$3.74$3.32829,304 shs$255.68 million03/10/2025$3.87$3.49-9.82%$3.86$3.33782,248 shs$239.23 million03/07/2025$3.61$3.87+7.20%$4.12$3.621.93 million shs$265.28 million03/06/2025$3.36$3.61+7.44%$3.69$3.24918,456 shs$247.46 million03/05/2025$3.01$3.36+11.63%$3.40$3.00749,205 shs$230.32 million03/04/2025$3.00$3.01+0.33%$3.17$2.601.71 million shs$206.33 million Related Companies Wave Life Sciences Stock Chart ARS Pharmaceuticals Stock Chart Calliditas Therapeutics AB (publ) Stock Chart Evotec Stock Chart Dyne Therapeutics Stock Chart Ardelyx Stock Chart Ocular Therapeutix Stock Chart Qilian International Holding Group Stock Chart Aurinia Pharmaceuticals Stock Chart Adaptive Biotechnologies Stock Chart Receive AMLX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Amylyx Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:AMLX) was last updated on 4/6/2025 by MarketBeat.com Staff From Our PartnersCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredHere’s How to Claim Your Stake in Elon’s Private Company, xAIEven though xAI is a private company, tech legend and angel investor Jeff Brown found a way for everyday folks...Brownstone Research | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredThree new patents reveal Elon and Trump’s secret “Project America”Right now for a limited time… You can get Tim Bohen’s top 5 Trump stocks for 2025… For only ONE DOLLAR!...Timothy Sykes | SponsoredDOGE Social Security bombshell?Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredTrump’s Final Plan Presidential insider exposes shocking plot to reshape U.S. economy: The 2025 Trump Reset -- Inside Trump’...Porter & Company | SponsoredWall St. Icon: Looming Financial Tsunami Could Wipe Out the 1%Wall Street icon who forecasted Black Monday and dot-com crash says a new economic event could hit the America...InvestorPlace | SponsoredControversial opinion: Volume isn't enough.Don’t be fooled by volume alone — it's just one piece of the trading puzzle. High demand doesn’t matter if sup...MillPub | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Amylyx Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Amylyx Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
